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Abstract 
 
Objective: To determine changes in supportive care needs after first-line treatment 
for ovarian cancer and identify risk factors for future unmet needs.  
 
Methods: 219 women with ovarian cancer were asked to complete a baseline 
survey 6-12 months after diagnosis then follow-up surveys every 6 months for up to 
2 years. The validated SCNS-SF34 measured 34 needs across 5 domains. Logistic 
regression identified baseline variables associated with future needs.  
 
Results: At baseline, standardized median scores (possible range 0-100, least-to- 
greatest need) within the psychological, system/information, physical, patient care 
and sexuality need domains were 25, 20, 15, 15 and 8, respectively. The most 
frequently reported moderate-to-high unmet needs at baseline were needing help 
with fear about cancer spreading (25%), concerns about worries of those close 
(20%), being informed about things to help get well (20%), uncertainty about future 
(19%) and lack of energy (18%). All except the item about being informed were still 
reported as unmet needs by ≥15% of women 2 years later. Median health 
system/information, patient care and sexuality need scores decreased over 2 years 
(p<0.05), whereas psychological and physical scores remained constant. Risk 
factors for having ≥1 moderate-to-high unmet overall, psychological or physical need 
1-2 years after baseline included older age, advanced disease, unmet need, anxiety, 
depression, insomnia and less social support at baseline. 
 
Conclusion: Women with ovarian cancer report needing ongoing assistance to deal 
with psychological and physical needs over the first 2 years after first-line treatment. 
Targeting individuals at risk of future unmet needs should be prioritized.  
 
 
Key words: ovarian cancer, oncology, needs assessment, supportive care, risk 
factors 
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Introduction 
 
Most women with ovarian cancer have advanced disease at diagnosis [1]. They are 
typically treated with surgery and six three-weekly cycles of adjuvant chemotherapy. 
While most women initially respond to treatment, 80% experience disease 
recurrence and go on to have multiple courses of chemotherapy over several years, 
before succumbing to their disease [1]. Survival is an important objective of 
treatment but, in the context of advanced disease and the debilitating side-effects of 
ongoing treatment, maximising quality of life is also a priority issue. Comprehensive 
care involves not only curative efforts, but also attention to a whole range of patient 
needs [2]. It is through meeting these needs that we can improve overall quality of 
life [3].  
 
Needs assessment tools explicitly assess the stated desire for some action or 
resource that will help the patient attain optimal well-being [4]. Such tools directly 
measure the gap between a person’s experience of a service and the actual service 
required [5], highlighting deficiencies in service delivery. Little information is available 
about the specific needs of women with ovarian cancer. The only published study to 
date, a cross-sectional single clinic sample of 50 women, reported that the most 
frequently reported needs were psychosocial, such as fear about the cancer 
returning or spreading [6]. While other studies include women with ovarian cancer 
among heterogeneous gynecological samples, these have been cross-sectional, 
mainly longer-term survivors [7-9] and/or convenience samples [9, 10] and do not 
separately report on women with ovarian cancer. The needs of women with ovarian 
cancer are likely to differ from those of other gynecological cancer subgroups, due to 
their predominantly late stage diagnosis and ongoing courses of chemotherapy.  
 
Some support needs are also likely to change over time. Studies of women with 
ovarian cancer have shown that compared to women undergoing first-line 
chemotherapy, those post- treatment have significantly higher physical and 
functional wellbeing [11], lower depression and better quality of life [12]. After initial 
treatment-associated clinical care, some needs may be resolved, or addressed by 
family, friends or community organisations, while others may remain unmet [13]. 
Only one longitudinal study has been published that assessed unmet needs of 
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cancer patients beyond the end of primary treatment. In this study, 30% of a mixed 
cancer group (including breast, prostate, colorectal, and gynecological cancer and 
non-Hodgkin’s lymphoma survivors) who were treated with curative intent reported 
more than five unmet needs at the end of treatment, and for 60% of these 
participants the situation did not improve by the 6 month post-treatment follow-up 
assessment [14].  
 
To date, younger age [5, 14-18], not living with a partner [7], living in rural areas [7, 
16], later stage disease [7, 8, 15], more extensive surgery [7], ever receiving  
chemotherapy [7, 16], radiotherapy [16], or hormone treatment [14, 18], less time 
since diagnosis/treatment [5, 17-19], less social support [18], anxiety [8, 14], 
depression [8, 14, 18], insomnia [20] and lower physical or mental quality of life [8, 
21] have been associated with greater levels of unmet need among cancer patients. 
However, these mostly cross-sectional studies cannot identify determinants of future 
unmet needs. The two studies that have reported on risk factors for future unmet 
needs are unlikely to apply to women with ovarian cancer as they have included 
heterogeneous samples of cancer patients who were either treated with curative 
intent [14] or were 1 to 1057 weeks after diagnosis at baseline and excluded patients 
if they commenced additional treatment [18].      
 
Our aim was to assess the prevalence of, and changes in, unmet supportive care 
needs after first-line treatment among women diagnosed with ovarian cancer and to 
identify factors at the end of first-line treatment that predict future unmet needs.  
 
Methods 
 
The study was a longitudinal population-based mail survey with five repeated 
measures of unmet supportive care needs. Ethics approval for the study was 
obtained from The University of Sydney and Queensland Institute of Medical 
Research Human Research Ethics Committees and all participating sites across 
Australia. 
 
Participants and procedures 
The flow of participant recruitment is outlined in Figure 1. Australian women with 
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invasive ovarian cancer diagnosed between 2002 and 2006 participating in the 
population-based case-control Australian Ovarian Cancer Study (AOCS) [22, 23] 
were invited to participate in a quality of life sub-study (AOCS-QoL). Women alive in 
May 2005 and women who joined AOCS after this date were contacted by letter. 
Consenting women were mailed identical ‘quality of life’ questionnaires at 6-monthly 
intervals for a period of 2 years [12, 20]. Thus there were five assessment points: 
Time 1 (baseline); Time 2 = 6 month follow-up; Time 3 = 12 month follow-up; Time 4 
= 18 month follow-up; Time 5 = 24 month follow-up.   
 
The current analysis includes women who completed the baseline AOCS-QoL 
questionnaire within 6-12 months after their cancer diagnosis, a point that 
approximated the end of first-line treatment, and who remained active in the study for 
at least 12 months (n=185). The follow-up time period of ≥12 and ≤24 months was 
selected as the focus of this analysis as it reflects medium-term survival, where initial 
unmet supportive care needs may become satisfied by available support or become 
non-existent due to recovery from or adjustment to cancer. It is also the time when 
ovarian cancer recurrence and further chemotherapy are most likely to occur.   
 
Outcome measure 
The Supportive Care Needs Survey-Short Form (SCNS-SF34) was used to assess 
unmet needs across five domains: psychological (10 items); physical and daily living 
(5 items); health system and information (11 items); patient care and support (5 
items); and sexuality (3 items). This tool asks participants to rate their need for help 
with each item over the past month on a 5-point scale where 1 = not applicable (no 
need), 2 = satisfied (need was met), 3 = low unmet need, 4 = moderate unmet need, 
and 5 = high unmet need. Summated Likert scale scores are standardized (range 0 
to 100) to allow comparison across need domains [24]. The SCNS-SF34 is a 
validated measure of unmet needs within the cancer population. Its five domains 
collectively accounted for 73% of the variance, with Cronbach’s alpha for individual 
domains ranging from 0.86 to 0.96 [24]. Individual needs items can be dichotomized 
into no need, need met, low unmet need (1-3) versus moderate-to-high unmet need 
(4-5) to assess the proportion of patients reporting individual unmet needs.  
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Potential risk factor variables measured 
Demographics:  
Age, marital status and education level were self-reported at recruitment for AOCS. 
Each participant’s postcode, accessed through AOCS records, was used to classify 
her as residing in a major city, or an inner regional, outer regional, remote or very 
remote area using the Accessibility/Remoteness Index of Australia [25].  
 
Disease and cancer symptom burden:  
i) Disease stage (FIGO - International Federation of Gynecology and Obstetrics) at 
diagnosis was extracted from medical records as part of the AOCS.  
ii) Ovarian cancer symptom burden was assessed using the 12-item additional 
concerns subscale of the Functional Assessment of Cancer Therapy–Ovarian 
(FACT-O) [26]. Scores range between 0-44, with higher scores indicating lower 
symptom burden.  
iii) Participants also self-reported whether they were receiving chemotherapy at the 
time of each survey.  
 
Psychological distress and insomnia:  
i) Anxiety and depression were assessed using the Hospital Anxiety and Depression 
Scale (HADS) [27]. Two sub-scales distinguish between ‘normal’ (0–7), ‘sub-clinical’ 
(8–10), and ‘clinical’ (11–21) anxiety and depression.  
ii) Insomnia was measured using the 7-item Insomnia Severity Index (ISI) [28]. 
Scores are classified as ‘normal’ (0-7), ‘sub-clinical’ (8-14), and ‘clinical’ (15-28) 
insomnia [20].  
 
Social support and use of support services/mental health treatment:  
i) Social support was assessed using the Duke University of North Carolina 
Functional Social Support Questionnaire [29]. Higher scores indicate greater 
support.  
ii) Patients were asked if they had had any treatment for mental health problems 
(seen a psychologist or psychiatrist, had medication, counseling/cognitive behavioral 
therapy) and if they had seen or attended any additional support services (social 
worker, other health professionals, support groups, education programs, 
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relaxation/meditation) in the past 3 months. Responses were recoded as “yes” or 
“no/don’t know.” 
 
Statistical analysis 
Analyses were conducted to compare representativeness of baseline characteristics 
and needs of women with and without follow-up data at 12 months. These included t-
test for normally distributed continuous variables, chi-square test for categorical 
variables and Wilcoxon-Mann-Whitney test for not normally distributed continuous 
variables.  
 
Since 13 to 59% of women (depending on domain) had standardised need score of 0 
at follow-up, these variables were not normally distributed or transformable. Hence 
standardized medians were used to compare the level of need (possible range 0-
100) in each domain at each time point. We explored change over time by 
comparing baseline to each follow-up point using Wilcoxon signed ranks test. Fifteen 
women (8%) had missing data at 1 or 2 of the 3 follow-up time-points analysed but 
remained active in the study (n=8 at 12 months, n=6 at 18 months and n=6 at 24 
months). Missing scores for these women were imputed as the average of their 
scores before and after the missing time-point(s).  
 
To identify priority need items, the point prevalence of individual items with 
moderate-to-high levels of unmet needs was calculated.  
 
To identify baseline risk factors associated with reporting at least one moderate or 
high unmet need at any time within the 12-24 month follow-up period, we used 
backwards stepwise logistic regression. Parametric models of continuous outcomes 
were not appropriate as not normally distributed data caused heteroscedastic 
residuals. We considered any report of need during a single follow-up period to avoid 
multiple analyses and thus the potential of type I error. Initial logistic regression 
models included all potential baseline risk factors and were adjusted for whether the 
woman was on chemotherapy at follow-up. Then, similarly to others [7], variables 
that were not statistically (p-value <0.05) or contextually significant were removed, 
where contextual significance was pre-specified as an odds ratio ≥ 2 or ≤ 0.5 or, for 
ordinal variables, a monotonic relationship with the outcome. This process was 
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repeated until only statistically or contextually significant variables remained. Then, 
for the final models, ordinal variables with a monotonic relationship to the outcome 
were fitted as continuous variables and adjacent levels of categorical variables were 
collapsed when the effects were similar. All models were adjusted for baseline needs 
in that domain.   
 
Results 
 
Participants 
Of the 798 women who participated in the AOCS-QoL study, 219 were recruited 
within 6-12 months after diagnosis (Figure 1). Eighty-four percent (n=185) of these 
women remained active in the study at the 12 month follow-up and contributed to the 
current analysis. Death was the primary reason for women dropping out (Figure 1).  
 
On average, women in our analysis were 59 years of age at diagnosis (SD = 10), 
most (76%) were married or living with their partner, over half (57%) had completed 
further education after high school, and lived in a major city (61%) and three-quarters 
(76%) were diagnosed with late stage disease (Table 1). The demographic 
characteristics of the 34 women who died or withdrew before the 12 month follow-up, 
and thus were not included in the analysis, were similar to those who were included, 
with the exception that they were more likely to have had higher baseline physical 
needs (p<0.01) (Table 1). 
 
Needs within the five domains over time  
At baseline, the standardized median scores (possible range 0 to 100) within the 
psychological, system/information, physical and patient care need domains were 25, 
20, 15 and 15, respectively (Figure 2). Sexuality needs were less common (median 
score = 8). Over the two year follow-up period, median psychological and physical 
need scores remained fairly constant, whereas median scores in the other domains 
decreased over time (Figure 2). On average, sexuality and patient care needs were 
either non-existent or completely met by 12 months and 24 months after baseline, 
respectively (p<0.001, p=0.011 for change over time, respectively). The level of 
system/information needs decreased to a median score of 11 by 24 months after 
baseline (p<0.001).  
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At baseline, 59% of women reported having at least one moderate or high unmet 
supportive care need (median 2, range 0-26). Two-thirds (65%) reported at least one 
unmet need at the 12, 18 or 24 month follow-up (median 2, range 0-33). Depending 
on the domain, 25%-60% of women who reported needs at the 12, 18 or 24 month 
follow-up had not reported them at baseline.   
 
Priority unmet need items 
Items reported with moderate-to-high levels of unmet need by 15% or more women 
at baseline are presented in Table 2. With the exception of ‘lack of energy/tiredness’ 
which belongs to the physical domain, the top unmet need items all came from within 
the psychological and system/information domains. The trajectories of individual 
items over time were similar to their corresponding domain scores. Items that were 
still reported as moderate-to-high unmet needs by at least 15% of women two years 
after baseline were: fear about their cancer spreading, concerns about the worries of 
those close, uncertainty about the future, lack of energy/tiredness, anxiety and worry 
that results of treatment are beyond their control.  
  
Baseline risk factors for having at least one moderate-to-high unmet need within the 
12-24 month follow-up period 
Statistically and/or contextually significant risk factors at baseline for having at least 
one moderate-to-high unmet need within the 12-24 month follow-up period, overall 
and in each supportive care need domain, are presented in Table 3. Overall, the risk 
factors were reporting any unmet need at baseline, being diagnosed with late stage 
disease, anxiety, insomnia and having a lower level of social support. As 
psychological and physical needs were the highest and remain constant over time, 
risk factors for these specific domains are also of importance. Risk factors for 
psychological needs were having an unmet psychological need at baseline, late 
stage disease, insomnia and having a lower level of social support. Risk factors for 
physical needs were having an unmet physical need at baseline, older age, late 
stage disease, depression and insomnia.    
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Discussion 
 
Our study is the first to consider the level of supportive care needs of cancer patients 
at more than two time points. Importantly, we discovered that women with ovarian 
cancer report consistent levels of psychological and physical needs and declining 
levels of system/information, patient care and sexuality needs over the two year 
period after first-line treatment. The persistence of psychological and physical needs 
may be due to women experiencing one or more disease recurrences and receiving 
follow-up chemotherapy [1], which can amplify physical and psychosocial issues 
[30]. This is confirmed in our sample with women who were on chemotherapy having 
higher odds of unmet needs.   
 
Our study also indicates that a substantial proportion of women with ovarian cancer 
report having unmet needs; 3 out of 5 women reported having moderate-to-high 
unmet needs at the end of first-line treatment and 2 out of 3 reported having 
moderate–to-high unmet needs 1 to 2 years later. Consistent with Armes et al’s 
study [14], scores at the end of first-line treatment were highest for the psychological 
and system/information need domains. Further, our study suggests that women with 
ovarian cancer appear to have higher levels of supportive care needs than women 
with other types of gynecological cancer (standardized median scores 0-25 vs 0-8 
[7]). This disparity is likely due to more women with ovarian cancer being diagnosed 
with late stage disease.  
 
In particular, we found that many women with ovarian cancer reported needing more 
psychological support to help them manage their worries about the cancer 
spreading, their family’s worries, and their future. They also frequently reported an 
ongoing need for help with their lack of energy. These care priorities are consistent 
with those identified in cross-sectional studies [5, 7, 15], and in the first prospective 
study that followed patients for 6 months after first-line treatment [14]. 
 
Like most other studies we found the risk factors for unmet supportive care needs 
varied across need domains, demonstrating the distinct nature of these constructs. 
However, we identified that current unmet needs, late stage disease, anxiety, 
insomnia and minimal social support at the end of first-line treatment could be used 
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as a set of screening variables to identify women with ovarian cancer who are likely 
to have unmet needs in the future. In addition, we showed that older age and 
depression at the end of first-line treatment are also important risk factors for future 
unmet physical needs.  
 
Screening, assessment and management of patients with cancer who experience 
emotional and/or social deficits is currently recommended in guidelines to ensure 
patients have the ability to cope [31]. Prospective evidence of the link between 
patient characteristics and future unmet needs is important, not just for supporting 
guidelines for targeted management of individuals experiencing anxiety, depression 
or a lack of social support, but also for the potential resource- and cost-saving effect 
on health care provisions.  
 
This study suggests a broader range of variables could be incorporated in screening. 
Identifying older women and those with late stage disease makes sense as they may 
have reduced physical capabilities, making the demands of daily living and their 
ability to cope in the context of advancing disease a more pertinent concern. The 
relationship of insomnia to unmet needs is a new and noteworthy finding as it 
remained significant after adjustment for anxiety, depression and symptom burden, 
issues it is known to be associated with [32]. Poor sleep is reported to affect daytime 
functioning via a clustering of symptoms including decreased mood and cognitive 
abilities (concentration, memory, attention), elevated anxiety, fatigue and physical 
pain/discomfort [32]. Thus it is not surprising that individuals suffering from a chronic 
sleep problem have, as we identified, ongoing needs for help with psychological, 
physical and patient care needs. With almost half (44%) of women with ovarian 
cancer reporting insomnia [20], screening for and addressing this risk factor has the 
potential to make a huge impact on reducing future needs.  
 
This was an Australia-wide population-based study that used a valid and reliable 
unmet needs assessment tool. It was the first study to track changes over time 
specifically in an ovarian cancer population. However, due to the nesting of this 
study within a larger study, the baseline survey was completed over a wide interval 
(6-12 months after diagnosis). Our results represent the average experience of a 
group of women, some of whom may have adjusted to their diagnosis while others 
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may have experienced a recurrence. The nature of ovarian cancer is reflected in 
many of our participants experiencing disease progression and some dying during 
the course of the study. Another 15% of participants missed some assessments but 
remained active in the study. For these women, we imputed an average of their 
scores before and after the missing time-point(s). Our results therefore assume the 
individuals’ trend over time. As needs decrease or remain constant this imputation 
may under represent needs at follow-up points. To more accurately measure 
changes in needs over time we limited the sample to women who remained active in 
the study 1 year after baseline. This also allowed for complete outcome data when 
modelling risk factors for unmet needs reported 1 to 2 years after baseline. The 
women who died or withdrew before the 1 year follow-up were more likely to have 
higher baseline physical needs. Our results are therefore likely to under represent 
the level of unmet physical needs as patients get sicker. While our sample 
characteristics are representative of Australian women with ovarian cancer [33], we 
had a limited sample size for multivariable modelling. Like others we used 
backwards stepwise logistic regression to limit over-specification of the final models 
[14] and considered the point estimates, not just p-values, to ensure that potentially 
important factors were not missed [7].       
 
In conclusion, our results suggest that health professionals and service providers 
should consider how to improve their care of psychological concerns and reduce 
fatigue in women with ovarian cancer beyond the end of primary treatment. 
Development of individualized care plans based on risk assessment for future needs 
and patient choice could be implemented at the end of first-line treatment. Future 
research is however required to identify the optimal tools for this and to test their 
implementation and cost-effectiveness in a clinical setting. Importantly, our 
supportive care needs study is one of the first with a longitudinal design and a 
focused sample of women with ovarian cancer. It provides evidence of what factors 
are likely to predict the risk of experiencing unresolved needs in this group who 
mostly experience advanced disease.  
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Table 1. Demographic and clinical characteristics and supportive care needs 
of participants at baseline (6-12 months after diagnosis) 
 Completed ≥12 
month follow-up 
assessment and 
were included in 
these analyses 
(n=185) 
Did not complete 
≥12 month follow-up 
assessment and 
were not included in 
these analyses 
(n=34) 
Difference between 
women with and 
without follow-up 
data at 12 months 
 
p-valuea 
Age (years), mean 
(SD) 
59 (10) 60 (10) 0.55 
Marital status      
    Current partner 76% 74% 0.98 
    Separated/divorced 18% 19%  
    Never 
married/partner 
7% 6%  
Education level    
 High school or less  43% 45% 0.94 
TAFE/college 39% 39%  
University educated  17% 15%  
Remoteness Areas Classification   
Major city  61% 71% 0.29 
Inner regional 26% 29%  
Outer regional 10% 0%  
Remote/very remote 3% 0%  
Disease stage (FIGO) at diagnosis   
    Early (I-II) 24% 15% 0.27 
    Late (III-IV) 76% 85%  
Psychological needsb  25 33 0.46 
Physical needsb 15 35 <0.01 
System/information 
needsb 
20 25 0.48 
Patient care needsb 15 25 0.11 
Sexuality needsb 8 8 0.99 
a Values based on t-test for means, chi-square test for categorical variables and Wilcoxon-Mann-
Whitney test for medians 
b Standardized median score (possible range from 0-100)  
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Table 2. Supportive Care Needs Survey items with a moderate or high unmet need reported by 15% or more women 
at baseline (6-12 months after diagnosis) and their trajectory over time.  
  Baseline Follow-up Domain 
 
Rank 
 
Item 
0  
months 
12 
months 
24  
months 
 
 
1  Fear about the cancer spreading  25% 16% 21% Psychological  
2  Concerns about the worries of those close to you 20% 16% 18% Psychological  
3  Being informed about things you can do to help yourself get well  20% 11% 6% System/Information 
4  Uncertainty about the future  19% 16% 19% Psychological  
5  Lack of energy/tiredness  18% 15% 15% Physical 
6 Anxiety 17% 11% 15% Psychological 
7  Worry that results of treatment are beyond your control  16% 13% 18% Psychological  
8 Being informed about cancer that is under control or diminishing 16% 10% 5% System/Information 
9 Having one member of staff with whom you can talk about all 
aspects of your condition, treatment, and follow-up 
16% 7% 4% System/Information 
10 Being informed about your test results as soon as feasible 16% 9% 3% System/Information 
11 Keeping a positive outlook 15% 8% 10% Psychological 
12 Feelings of sadness  15% 7% 12% Psychological 
13 Being treated like a person not just another case 15% 3% 4% System/Information 
Note: ranking based on baseline then subsequent time-points 
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Table 3. Statistically and/or contextuallya significant risk factors for moderate/high unmet 
needs at 12-24 months after baseline (T1)b  (n=169c) 
 Odds ratio 
(95% confidence 
interval) 
 
p-value 
Overall needs   
T1 any need: moderate/high vs no/met/low need 2.9 (1.2, 6.6) 0.01 
FIGO stage at diagnosis: III-IV vs I-II 2.5 (0.9, 6.4) 0.07 
On chemotherapy during any follow-up: yes vs no 6.1 (2.4, 15.5) <0.01 
T1 anxiety: sub-clinical/clinical vs normal 2.9 (1.0, 8.3) 0.04 
T1 insomnia: sub-clinical/clinical vs normal 2.1 (0.9, 4.9) 0.10 
T1 social support: per unit change 0.91 (0.84,0.98) 0.02 
Psychological needs   
T1 psychological need: moderate/high vs no/met/low need 4.7 (2.2, 10.0) <0.01 
FIGO stage at diagnosis: III-IV vs I-II 2.9 (1.2, 6.9) 0.02 
T1 insomnia: sub-clinical/clinical vs normal 2.0 (1.0, 4.1) 0.07 
T1 social support: per unit change 0.92 (0.86, 0.98) 0.01 
Physical needs   
T1 physical need: moderate/high vs no/met/low need 2.4 (1.0, 5.7) 0.04 
Age, years: per unit change 1.03 (0.99, 1.07) 0.13 
FIGO stage at diagnosis: III-IV vs I-II 2.2 (0.8, 6.4) 0.14 
On chemotherapy during any follow-up: yes vs no 4.7 (2.1, 10.4) <0.01 
T1 depression: sub-clinical/clinical vs normal 3.5 (1.1, 11.4) 0.04 
T1 insomnia: sub-clinical/clinical vs normal 2.9 (1.4, 6.4) 0.01 
System/information needs   
T1 system/information need: moderate/high vs no/met/low need 4.1 (1.8, 9.1) <0.01 
Marital status: current partner vs no partner 2.3 (0.8, 6.0) 0.11 
Education: further education vs high school or less 2.2 (0.9, 5.1)  0.07 
FIGO stage at diagnosis: III-IV vs I-II 2.6 (0.8, 8.0) 0.10 
T1 cancer symptoms burden: top third vs rest 2.4 (1.0, 5.8) 0.05 
On chemotherapy during any follow-up: yes vs no 2.8 (1.2, 6.5) 0.02 
T1 social support: per unit change 0.92 (0.86, 0.99) 0.02 
Patient care needs   
T1 patient care need: moderate/high vs no/met/low need 4.5 (1.6, 12.3) <0.01 
T1 cancer symptoms burden: top third vs rest 2.1 (0.8, 5.6) 0.13 
T1 insomnia: sub-clinical/clinical vs normal 2.0 (0.8, 5.5) 0.16 
T1 social support: per unit change 0.94 (0.88, 1.01) 0.07 
Sexuality needs   
T1 sexuality need: moderate/high vs no/met/low need 5.4 (1.8, 16.4) <0.01 
T1 anxiety: sub-clinical/clinical vs normal 3.2 (1.1, 9.0) 0.03 
T1 social support: per unit change 0.95 (0.88, 1.02) 0.17 
T1 support service use/mental health treatment: yes vs no  3.3 (1.2, 9.1) 0.03 
a Contextually significant = odds ratio ≥ 2 or ≤ 0.5 or, for ordinal variables, a monotonic relationship with the outcome. 
b Baseline/T1 = 6-12 months after diagnosis 
c 16 participants with missing values across covariates 
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Figure 1 Flow of participant recruitment  
 
 
  
AOCS 
• Australia Ovarian Cancer Study: invasive cancer (n=1618) 
QoL 
• Quality of Life nested longitudinal study (n=798) 
Subgroup 
• Recruited to Quality of Life study 6-12 months after diagnosis (n=219)  
Analysed 
• 12 month follow-up data (n=185 of which 8 were imputed) 
• Withdrawals: death = 22, incapacity = 2, unknown = 10 
• 18 month follow-up data (n=165 of which 6 were imputed)  
• Withdrawals: death = 18, unknown = 2 
• 24 month follow-up data (n=148 of which 6 were imputed) 
• Withdrawals: death = 15, incapacity = 1, unknown = 1   
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Figure 2. Standardized need domain scores over time after baseline (6-12 
months after diagnosis) 
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